New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 15, 2012
10:06 EDTSAFM, CTIC, TRLA, GAIN, TRN, NBHC, TRAK, NOW, KEYW, CBF, OMEROn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Capital Bank (CBF) initiated with a Market Perform at Keefe Bruyette... Capital Bank (CBF) initiated with a Neutral at Goldman... DealerTrack (TRAK) initiated with an Overweight at Evercore... Gladstone Investment (GAIN) initiated with a Buy at Jefferies... KEYW (KEYW) initiated with an Outperform at RBC Capital... National Bank (NBHC) initiated with an Outperform at Keefe Bruyette... Omeros (OMER) initiated with an Outperform at Burrill... ServiceNow (NOW) initiated with an Equal Weight at Evercore... Trinity Industries (TRN) initiated with a Buy at UBS... Trulia (TRLA) initiated with a Neutral at JPMorgan... Trulia (TRLA) initiated with an Outperform at RBC Capital... Trulia (TRLA) initiated with a Buy at Needham... Cell Therapeutics (CTIC) initiated with a Buy at ThinkEquity... Sanderson Farms (SAFM) initiated with a Buy at Sidoti.
News For CBF;TRAK;GAIN;KEYW;NBHC;OMER;NOW;TRN;TRLA;CTIC;SAFM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
December 12, 2014
08:26 EDTNOWServiceNow says pipeline has never looked better, says JMP Securities
Subscribe for More Information
December 11, 2014
16:26 EDTNOWServiceNow initiated with a Neutral at Piper Jaffray
Subscribe for More Information
December 10, 2014
13:45 EDTKEYWKEYW management to meet with SunTrust
Meetings to be held on the West Coast December 15-18 hosted by SunTrust.
12:06 EDTSAFMUSDA lowers 2014 meat production forecast
Subscribe for More Information
10:00 EDTNOWOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: 3D Systems (DDD) initiated with an Underperform at Longbow... AutoZone (AZO) initiated with a Buy at Nomura... C.H. Robinson (CHRW) initiated with a Neutral at Nomura... CSX (CSX) initiated with a Buy at Nomura... CVS Health (CVS) initiated with a Neutral at Citigroup... Canadian National (CNI) initiated with a Neutral at Nomura... Carrizo Oil & Gas (CRZO) initiated with a Buy at Canaccord... CenterPoint Energy (CNP) initiated with a Neutral at Nomura... Con-way (CNW) initiated with a Neutral at Nomura... Cornerstone OnDemand (CSOD) initiated with a Buy at BofA/Merrill... Depomed (DEPO) initiated with an Outperform at RBC Capital... Dollar General (DG) initiated with a Buy at Citigroup... Dollar Tree (DLTR) initiated with a Neutral at Citigroup... Dynagas LNG (DLNG) initiated with a Buy at ABN Amro... EMC (EMC) initiated with a Neutral at JPMorgan... Energy Focus (EFOI) initiated with a Buy at Roth Capital... Expeditors (EXPD) initiated with a Neutral at Nomura... GasLog (GLOG) initiated with a Buy at ABN Amro... Genesee & Wyoming (GWR) initiated with a Neutral at Nomura... Golar LNG (GLNG) initiated with a Sell at ABN Amro... HII Technologies (HIIT) initiated with a Buy at Roth Capital... Hudbay Minerals (HBM) initiated with an Overweight at Barclays... J.B. Hunt (JBHT) initiated with a Buy at Nomura... Kansas City Southern (KSU) initiated with a Buy at Nomura... Kroger (KR) initiated with a Buy at Citigroup... Lear (LEA) initiated with a Buy at Northcoast... Lundin Mining (LUNMF) initiated with an Overweight at Barclays... NetApp (NTAP) initiated with a Neutral at JPMorgan... Norfolk Southern (NSC) initiated with a Neutral at Nomura... PROS (PRO) initiated with an Outperform at Pacific Crest... Qlik Technologies (QLIK)initiated with a Buy at BofA/Merrill... Rentokil (RTOKY) initiated with a Neutral at UBS... Revolution Lighting (RVLT) initiated with a Buy at Roth Capital... ServiceNow (NOW) initiated with a Buy at BofA/Merrill... Stratasys (SSYS) initiated with a Neutral at Longbow... Suburban Propane (SPH) initiated with a Hold at Stifel... Tableau (DATA) initiated with a Buy at BofA/Merrill... Teekay LNG (TGP) initiated with a Buy at ABN Amro... Tessera (TSRA) initiated with a Buy at Sidoti... Union Pacific (UNP) initiated with a Buy at Nomura... Viper Energy (VNOM) initiated with a Buy at Stifel... Visteon (VC) initiated with a Buy at Northcoast... Walgreen (WAG) initiated with a Buy at Citigroup... Werner (WERN) initiated with a Neutral at Nomura.
09:48 EDTKEYWHexic Cyber Solutions announce strategic distribution alliance with Promark
Subscribe for More Information
08:16 EDTNOWBarclays to hold a conference
Global Technology Conference is being held in San Francisco on December 9-10 with webcasted company presentations to begin on December 10 at 10:40 am; not all company presentations may be webcasted.Webcast Link
06:47 EDTNOWServiceNow initiated with a Buy at BofA/Merrill
Target $75.
06:37 EDTTRNNew crash tests to be conducted on Trinity Industries guardrail, NY Times says
New crash tests will be conducted on Trinity Industries' troubled ET-Plus guardrail today, according to The New York Times. The tests will be similar to tests performed nearly a decade ago when the current version of the product was introduced, the newspaper stated. However, the Federal Highway Administration indicated that it could use other types of tests in the future to gauge the effectiveness of the ET-Plus, which has been banned by more than 30 states, the newspaper reported. Reference Link
December 9, 2014
07:41 EDTTRAKBarclays to hold a conference
Global Technology Conference is being held in San Francisco on December 9-10 with webcasted company presentations to begin on December 9 at 10:40 am; not all company presentations may be webcasted. Webcast Link
05:56 EDTCTICCTI BioPharma presents Pacritinib data at ASH meeting
Subscribe for More Information
December 8, 2014
07:28 EDTNOWFBN Securities to hold a bus tour
Subscribe for More Information
December 7, 2014
14:25 EDTCTICCTI BioPharma announces analysis of kinase inhibition by pacritinib
CTI BioPharma announced that an analysis of kinase inhibition by pacritinib, a next generation oral multikinase inhibitor in Phase 3 clinical development, demonstrated a unique kinome profile among agents in development for myelofibrosis and suggests potential therapeutic benefit across a spectrum of blood-related cancers. Researchers presented the findings from this analysis at the 56th American Society of Hematology Annual Meeting and Exposition held December 6-9 in San Francisco, CA."The kinome profile of pacritinib shown in this analysis highlights how pacritinib is different from other JAK inhibitors that are currently on the market and in development for myelofibrosis," said Srdan Verstovsek, M.D., Ph.D., Director, Clinical Research Center for MPNs at The University of Texas MD Anderson Cancer Center and principal investigator for the Phase 3 PERSIST-2 trial of pacritinib. "One of the findings observed in clinical trials to date is the lack of myelosuppression seen with other treatments. Pacritinib's potent inhibition of FLT3, c-fms, IRAK1 and c-kit, all critical targets in hematologic malignancies, highlights its potential therapeutic utility in other indications, such as AML, MDS, CMML and CLL." The in vitro profiling of pacritinib across a panel of kinases showed the inhibition of all members of the JAK/FLT pathways, with the exception of JAK1. The JAK/FLT pathways are frequently dysregulated in many types of cancers. Additionally, pacritinib was found to inhibit the kinases c-fms and IRAK1. Disruption in the c-fms and IRAK1 pathways have been indicated to be involved in acute myeloid leukemia, myelodysplastic syndrome, chronic myelomonocytic leukemia and chronic lymphocytic leukemia. CTI believes the clinical efficacy and reduced myelosuppression seen in Phase 2 trials of pacritinib in patients with myelofibrosis is also likely attributable to this unique kinase inhibition profile. "These data not only demonstrate the unique attributes of pacritinib compared to other marketed agents or agents in development for the treatment of myelofibrosis, many of which have activity against JAK1, but also show the potential for broader use in other blood-related cancers," said Jack Singer, M.D., Executive Vice President, Global Medical and Translational Medicine at CTI and lead author of the analysis. "We are excited to pursue additional indications, such as AML, MDS, CMML and CLL, all of which are currently being evaluated in Phase 2 clinical trials, so we can potentially offer these patients an effective and less toxic treatment option."
14:10 EDTCTICAmerican Society of Hematology to hold a meeting
Subscribe for More Information
14:08 EDTCTICCTI BioPharma to hold a cocktail reception
Subscribe for More Information
December 4, 2014
14:01 EDTTRAKDealerTrack could significantly broaden scope with incadea buy, says Wells Fargo
After DealerTrack confirmed that it is in talks to acquire incadea, Wells Fargo noted that the German company trades for about 27x 2014 EPS, which is slightly below DealerTrack's valuation. The firm said it believes such a deal would significantly broaden DealerTrack's scope and give it further opportunity to leverage its platform. Wells has an Outperform rating on DealerTrack shares.
10:48 EDTTRAKDealerTrack confirms preliminary discussions with incadea
Dealertrack confirms the announcement made by incadea that it is in discussion with incadea regarding a possible acquisition with incadea, an international provider of enterprise software solutions and services to the global automotive retail market. The discussions with incadea are preliminary in nature and any offer will be subject to various pre-conditions, including due diligence, and there can be no certainty that an offer will ultimately be forthcoming or on the terms on which any offer might be made for incadea. This announcement does not represent a firm intention to make an offer under Rule 2.7 of the United Kingdom City Code on Takeovers and Mergers. Accordingly, there can be no certainty that any offer will ultimately be made for incadea. A further announcement will be made if and when appropriate.
09:23 EDTCTICOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Avago (AVGO), up 7.2%... Kroger (KR), up 3.1%... Rite Aid (RAD), up 3.1%... Sears Holdings (SHLD), up 2.3%. ALSO HIGHER: Array Biopharma (ARRY), up 24% after reaching a definitive agreement with Novartis (NVS) to regain full worldwide rights to binimetinib... Hawaiian Electric (HE), up 13.5% following merger announcement with NextEra Energy (NEE)... SinoCoking Coal (SCOK), up 14.2% after beginning construction of second aboveground Syngas facility... Plug Power (PLUG), up 12.3% after announcing $20M ReliOn fuel cell contract... Mobileye (MBLY), up 3.4% after being upgraded to Buy from Hold at Deutsche Bank... CTI BioPharma (CTIC), up 3.6% following $15M payment from Teva for TRISENOX... TASER (TASR), up 3% after receiving multiple orders of AXON body cameras. DOWN AFTER EARNINGS: Barnes & Noble (BKS), down 7.6%... Express (EXPR), down 11.3%... Toronto-Dominion Bank (TD), down 1.4%... Toro Company (TTC), down 1.1%... Aeropostale (ARO), down 14.1%. ALSO LOWER: Kindred Biosciences (KIN), down 29.3% after announcing that it will discontinue its AtoKin study... UTi Worldwide (UTIW), down 13% after saying that there are no current talks with DSV A/S... Agree Realty (ADC), down 3.7% after 2.1M share Spot Secondary priced at $29.90.
07:49 EDTSAFMSanderson Farms price target raised to $95 from $90 at Stephens
Subscribe for More Information
05:30 EDTCTICCTI BioPharma receives $15M payment from Teva for TRISENOX
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use